» Articles » PMID: 16049916

Genome-wide Array-based Comparative Genomic Hybridization of Natural Killer Cell Lymphoma/leukemia: Different Genomic Alteration Patterns of Aggressive NK-cell Leukemia and Extranodal Nk/T-cell Lymphoma, Nasal Type

Overview
Date 2005 Jul 29
PMID 16049916
Citations 65
Authors
Affiliations
Soon will be listed here.
Abstract

Natural killer (NK) cell lymphomas/leukemias are highly aggressive lymphoid malignancies, but little is known about their genomic alterations, and thus there is an urgent need for identification and analysis of NK cell lymphomas/leukemias. Recently, we developed our own array-based comparative genomic hybridization (array CGH) with an average resolution of 1.3 Mb. We performed an array CGH analysis for 27 NK-cell lymphoma/leukemia cases that were classified into two disease groups based on the World Health Organization Classification (10 aggressive NK-cell leukemia cases and 17 extranodal NK/T-cell [NK/T] lymphomas, nasal type). We identified the differences in the genomic alteration patterns of the two groups. The recurrent regions characteristic of the aggressive NK-cell leukemia group compared with those of the extranodal NK/T lymphoma, nasal-type group, were gain of 1q and loss of 7p15.1-p22.3 and 17p13.1. In particular, gain of 1q23.1-24.2 (P = 0.041) and 1q31.3-q44 (P = 0.003-0.047), and loss of 7p15.1-p22.3 (P = 0.012-0.041) and 17p13.1 (P = 0.012) occurred significantly more frequently in the former than in the latter group. Recurrent regions characteristic of the extranodal NK/T lymphoma, nasal-type group, compared with those of the other group were gain of 2q, and loss of 6q16.1-q27, 11q22.3-q23.3, 5p14.1-p14.3, 5q34-q35.3, 1p36.23-p36.33, 2p16.1-p16.3, 4q12, and 4q31.3-q32.1. Our results can be expected to provide further insights into the genetic basis of lymphomagenesis and the clinicopathologic features of NK-cell lymphomas/leukemias.

Citing Articles

A differential diagnosis method for systemic CAEBV and the prospect of EBV-related immune cell markers via flow cytometry.

Jin J, Mao X, Zhang D Ann Med. 2024; 56(1):2329136.

PMID: 38502913 PMC: 10953786. DOI: 10.1080/07853890.2024.2329136.


Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders.

Lewis N, Zhou T, Dogan A Haematologica. 2023; 108(12):3261-3277.

PMID: 38037802 PMC: 10690927. DOI: 10.3324/haematol.2023.282718.


Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?.

Costa R, Pereira J, Lage L, Baiocchi O Front Oncol. 2023; 13:1175545.

PMID: 37529691 PMC: 10388588. DOI: 10.3389/fonc.2023.1175545.


Extranodal natural killer/T-cell lymphoma with hepatosplenic involvement: a retrospective study of a consecutive 14-year case series.

Zhang Y, Li Z, Zhao S, Zhang W, Liu Q, Liu W Ann Hematol. 2023; 102(10):2803-2813.

PMID: 37434096 DOI: 10.1007/s00277-023-05358-4.


Mature T-cell and NK-cell lymphomas: updates on molecular genetic features.

Lewis N, Sardana R, Dogan A Int J Hematol. 2023; 117(4):475-491.

PMID: 36637656 DOI: 10.1007/s12185-023-03537-7.